Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.

World shares were mixed on Tuesday after U.S. stock indexes inched to more records at the start of a week of profit updates ...

World shares were mixed on Tuesday after US stock indexes inched to more records at the start of a week of profit updates ...

Shares in Sarepta Therapeutics have slumped by more than a third since late last week amid new updates on its gene therapy ...